Skip to content
2000
  1. Home
  2. A-Z Publications
  3. Current Organic Synthesis
  4. Fast Track Articles
  5. Fast Track Article
image of Synthesis and Characterization of 3-S-impurities in Timolol Maleate

Abstract

Background

Timolol maleate is clinically used for the treatment of hypertension, angina pectoris, tachycardia, and glaucoma.

Objective

The aim of this study was to enhance the safe use of timolol maleate and investigate a synthesis method for 3-S-timolol, a newly identified impurity in timolol API (Active Pharmaceutical Ingredients).

Methods

()-3-(-butylamino)propane-1,2-diol () was used as a raw material. 3-S-timolol maleate () was synthesized through a five-step reaction. Overall yield was 57.7%, with a purity of 98%.

Results

The structure of the target compound was confirmed analysis of its 1H nuclear magnetic resonance, 13C nuclear magnetic resonance, and high-resolution mass spectrometry spectra.

Conclusion

The synthesis method was straightforward and yielded a high-purity product suitable for use as a reference in the analysis and identification of timolol maleate-related substances.

© 2025 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/cos/10.2174/0115701794344307241027093947
2025-01-30
2025-05-04

  • From This Site

    /content/journals/cos/10.2174/0115701794344307241027093947
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. Pakzad Y. Fathi M. Omidi Y. Mozafari M. Zamanian A. Synthesis and characterization of timolol maleate-loaded quaternized chitosan-based thermosensitive hydrogel: A transparent topical ocular delivery system for the treatment of glaucoma. Int. J. Biol. Macromol. 2020 159 117 128 10.1016/j.ijbiomac.2020.04.274 32380105
    [Google Scholar]
  2. Jun I. Choi Y.J. Kim B.R. Seo K.Y. Kim T. Activation of ADRB2/PKA signaling pathway facilitates lipid synthesis in meibocytes, and beta-blocker glaucoma drug impedes PKA-induced lipid synthesis by inhibiting ADRB2. Int. J. Mol. Sci. 2022 23 16 9478 10.3390/ijms23169478 36012741
    [Google Scholar]
  3. May G. Miller D. Fuchs D. Bradycardia from a non-selective beta-adrenergic antagonist, timolol, applied ophthalmologically for glaucoma. Cureus 2022 14 6 e25815 10.7759/cureus.25815 35822138
    [Google Scholar]
  4. Hagan J.C. III First world literature report: Attention pharma & headache researchers! Nasal spray timolol may be the next great thing for acute migraine. Mo. Med. 2024 121 1 4 5 38404425
    [Google Scholar]
  5. Kosa S.C. Hagan J.C. III Nasally delivered 0.5% timolol beta blocker successfully treats acute migraines in a referral headache clinic: A case series. Mo. Med. 2024 121 1 33 36 38404426
    [Google Scholar]
  6. Hongjian Zhu Hua Luo Wenjuan Lai Efficacy of timolol in the treatment of facial hemangioma and its effect on the proliferation and apoptosis of hemangioma stem cells. Cell. Mol. Biol. 2023 69 10 115 120 10.14715/cmb/2023.69.10.16 37953576
    [Google Scholar]
  7. Han K. Wei J.J. Zheng H. Li X.D. Zhang A.X. Ma Y.H. Meng J. Hu Y.Y. Efficacy and safety of oral propranolol or topical timolol for the treatment of superficial infantile hemangiomas. Craniofacial surgery 2024 35 254 257 10.1097/SCS.0000000000010001
    [Google Scholar]
  8. Lopez-Bernal T. Aranegui B. RF-FTopical Timolol in dermatology Actas dermo- sifiliograficas 2023 114 4 334 335 10.1016/j.ad.2021.09.014
    [Google Scholar]
  9. Toker M. Antohi D.R. Srivastava P. Amin B. Wu B. COVID–19-associated diffuse dermal angiomatosis managed with pentoxifylline and topical timolol. JAAD Case Rep. 2023 39 34 36 10.1016/j.jdcr.2023.07.002 37593377
    [Google Scholar]
  10. Gummi R. Stahl E.D. Marsh J.D. Topical timolol for an iris hemangioma. J. AAPOS 2018 22 2 156 158 10.1016/j.jaapos.2017.10.015 29412149
    [Google Scholar]
  11. Yin R.R. Hao D. Wu Q. Wang J. Wang B.H. Chen P. Feng Y.T. Ji R.F. Clinical observation of topical timolol maleate ophthalmic solution for the treatment of superficial infantile hemangiomas of the scalp. J. Clin. Dermatol 2022 51 299 302 10.16761/j.cnki.1000‑4963.2022.05.015
    [Google Scholar]
  12. Mazhar A. Ghouse A.N. Mallick Y.A. Samad L. Efficacy of 0.5% timolol maleate gel in the management of infantile hemangiomas. Pak. J. Med. Sci. 2023 40 2(ICON) Suppl. S75 S79 10.12669/pjms.40.2(ICON).8983 38328662
    [Google Scholar]
  13. Alzaid M. Al-Naseem A. Al-Niaimi F. Ali F.R. Topical timolol in dermatology: Infantile haemangiomas and beyond. Clin. Exp. Dermatol. 2022 47 5 819 832 10.1111/ced.15021 34798680
    [Google Scholar]
  14. Agrawal S. Modaboyina S. Bajaj M.S. Gupta S. Das D. Effectiveness of treatment of acquired capillary haemangioma using timolol. Clin. Exp. Optom. 2022 105 5 556 557 10.1080/08164622.2021.1952843 34315341
    [Google Scholar]
  15. Hildebrand G.D. Sipkova Z. Topical Timolol for infantile haemangioma of the orbit. Klin. Monatsbl. Augenheilkd. 2021 238 10 1069 1076 10.1055/a‑1645‑1665 34662921
    [Google Scholar]
  16. Hwang A.S. Hoss E. Pittelkow M.R. Yang Y.W. Treatment of Hydroxyurea-induced ulcers with Timolol. JAMA Dermatol. 2023 159 11 1277 1279 10.1001/jamadermatol.2023.2765 37728912
    [Google Scholar]
  17. Priluck A. Bacorn C. Rajaii F. Rapid involution of presumed pyogenic granuloma with topical Timolol. Ophthalmology 2023 130 1 27 10.1016/j.ophtha.2022.04.019 35777985
    [Google Scholar]
  18. Brent G. Al-Wahab Y. Natkunarajah J. Topical timolol 0.5% as a novel therapeutic approach for Hailey–Hailey disease. Clin. Exp. Dermatol. 2023 49 1 76 78 10.1093/ced/llad296 37652061
    [Google Scholar]
  19. Pawar M.K. Treatment of painful and deep fissures of the heel with topical timolol. J. Am. Acad. Dermatol. 2021 85 1 e3 e4 10.1016/j.jaad.2020.05.100 32479981
    [Google Scholar]
  20. Abdelmaksoud A. Filoni A. Giudice G. Vestita M. Topical timolol for Kaposi sarcoma: An innovation. Australas. J. Dermatol. 2018 59 4 340 341 10.1111/ajd.12817 29624656
    [Google Scholar]
  21. Volotinen M. Hakkola J. Pelkonen O. Vapaatalo H. Mäenpää J. Metabolism of ophthalmic timolol: New aspects of an old drug. Basic Clin. Pharmacol. Toxicol. 2011 108 5 297 303 10.1111/j.1742‑7843.2011.00694.x 21385322
    [Google Scholar]
  22. British Pharmacopoeia The Stationery Officon behalf of the Medicines and Healthcare products Regulatory Agency（MHRA) London 2016 2 1080 1082
    [Google Scholar]
  23. Shui Q.H. Li Z.M. Yu S.M. Determination of the related substances in timolol maleate eye drops by HPLC. Food and Drug 2005 7 41 42
    [Google Scholar]
  24. Hu B. Shan X.Y. Determination of related substances in Timolol Maleate eye drops by HPLC. Chinese Pharmacists 2012 12 1138 1140
    [Google Scholar]
  25. Liu H.Y. Cheng Q.Z. Zhou M. Yi Q. Determination of related substance and impurities qualitative study of Timolol Maleate eye drops. Chinese Pharmacy 2018 29 2208 2214
    [Google Scholar]
  26. Tian H. Wu C.M. Yan Q.H. Identification and determination of related substances of timolol maleate. J. Pharm. Anal. 2024 44 450 461 10.16155/j.0254‑1793.2024.03.10
    [Google Scholar]
  27. Fei L.H. Fei H.Y. Wu J. Determination of Timolol Maleate and related substances in Travoprost and Timolol Maleate eye drops by HPLC. Herald of Medicine 2022 41 11 1676 1680
    [Google Scholar]
  28. Ji X.R. Liu Y.Y. Gao Z. Kong Y. Determination of related substances in Timolol Maleate by HPLC. Pharm. Biotechnol. 2021 28 3 261 265 10.19526/j.cnki.1005‑8915.20210308
    [Google Scholar]
  29. Huo X.M. Determination of related substances in Timolol Maleate and its eye drops by reversed phase Ion-pair HPLC. J. Pharm. Anal. 2000 20 03 181 184 10.16155/j.0254‑1793.2000.03.016
    [Google Scholar]
  30. Lacroix P.M. Dawson B.A. Sears R.W. Black B. HPLC and NMR methods for the quantitation of the (R)-enantiomer in (-)-(S)-timolol maleate drug raw materials. Chirality 1994 6 6 484 491 10.1002/chir.530060607
    [Google Scholar]
  31. Djang’eing’a Marini R. Chiap P. Boulanger B. Dewe W. Hubert P. Crommen J. LC method for the simultaneous determination of R ‐timolol and other closely related impurities in S ‐timolol maleate: Optimization by use of an experimental design. J. Sep. Sci. 2003 26 9-10 809 817 10.1002/jssc.200301367
    [Google Scholar]
  32. Sharma N. Rao S.S. Reddy A.M. A novel and rapid validated stability-indicating UPLC method of related substances for dorzolamide hydrochloride and timolol maleate in ophthalmic dosage form. J. Chromatogr. Sci. 2012 50 9 745 755 10.1093/chromsci/bms025 22562819
    [Google Scholar]
  33. Zhou Z.H. Zuo B. Ma X.X. Wu L. Synthesis and characterization of (S)-Timolol Hemihydrate. J. Wuhan Univ. Technol 2020 42 628 632 10.19843/j.cnki.CN42‑1779/TQ.202004012
    [Google Scholar]
  34. Huang J.X. Yu G.G. Li M.X. A new method for synthesis of (E)-6- I-3-methyl-2 -ethyl enlate Chemical notification 1999 2 49 51
    [Google Scholar]
  35. Liao F. Xiao Y. Li X. Yu Z.Y. Liu X.C. progress of Synthesis of 1-Hydroxyeth oxyethyl- piperazine. Chemistry&Bioengineering 2015 32 3 18 20 10.3969/j.issn.1672‑5425.2015.03.004
    [Google Scholar]
  36. Sun C.B. Zhang Z.B. Chen Y.Z. Kuang Y.H. Liao X.J. Feng P.J. One-pot, three-step synthesis of o-Aminophenol derivatives from nitro arenes. Univ.Chem 2022 37 5 1 8 10.3866/PKU.DXHX202111018
    [Google Scholar]
  37. Li C. Wang X. Posaconazole synthetic route diagram. Chin. J. Chem 2020 30 3 182 186 10.14142/j.cnki.cn21‑1313/r.2020.03.008
    [Google Scholar]
  38. Li Y. Study on Synthesis and Activity of New Timolol Analogues. Jilin Agricultural University 2013
    [Google Scholar]
  39. Gao G.T. Improved synthesis of 3-(3-chloro-1‚2‚5- thiadiazol-4-yl)pyridine. Z red fruit Y aw hu A point za value 2007 17 3 180 182
    [Google Scholar]
  40. Xia R. Yang S.H. Sun L.P. Qu G.R. New synthesis of 2-Thioadenosine. Chemical Reagents 2016 38 1 70 72 10.13822/j.cnki.hxsj.2016.01.017
    [Google Scholar]
  41. Meguro Y. Noguchi M. Li G.F. Shoda S.I. Efficient generation of thiolate sugars from glycosyl Bunte salts and its application to S-glycoside synthesis. Tetrahedron Letters 2020 61 36 152198 10.1016/j.tetlet.2020.152198
    [Google Scholar]
  42. Zhou Z.S. Zhu J.L. Synthesis of optically active timolol. Chem. J. Chin. Univ. 1988 9 743 745
    [Google Scholar]
  43. Zhou J.H. Sun S.S. Yin H.X. Xu C.M. Wang Y.Y. Research of the synthesis of chiral drug S-(-)-Timolol. J. Jining Med. Coll 2006 29 02 27 30
    [Google Scholar]
  44. Saddique F.A. Zahoor A.F. Yousaf M. Irfan M. Ahmad M. Mansha A. Khan Z.A. Naqvi S.A.R. Synthetic approaches towards the synthesis of beta-blockers (betaxolol, metoprolol, sotalol, and timolol). Turk. J. Chem. 2016 40 2 193 224 10.3906/kim‑1504‑65
    [Google Scholar]
  45. Kamal A. Krishnaji T. Khan M.N.A. Lipase-catalyzed resolution of 1-chloro-3-[(4-morpholin-4-yl-1,2,5-thiadiazole-3-yl)oxy]propan-2-ol. J. Mol. Catal., B Enzym. 2008 54 1-2 55 59 10.1016/j.molcatb.2007.12.003
    [Google Scholar]
  46. Wang D.C. Lu W. Zhou G.L. Yan H.Y. Synthesis of timolol tartrate and preliminarystudies on its lowering the intraocular pressure. Chin. J. Chem 1994 4 4 289 291
    [Google Scholar]
  47. Xu L. He J.F. Yang L.M. Preparation of cellulose tris(benzoate)s and thin-layer chromatographic separation of (DL)-Timolo Guangdong Chem. Indus 2007 34 9 55 57
    [Google Scholar]
  48. Baeva L.A. Biktasheva L.F. Nikitina T.S. Fatykhov A.A. Lyapina N.K. Synthesis of 1,1′-{3-[(alkylsulfanyl)methyl]-tetrahydro-2H-thiopyran-3,5-diyl}diethanones from sodium sulfide and thiols. Chem. Heterocycl. Compd. 2012 48 4 601 605 10.1007/s10593‑012‑1032‑0
    [Google Scholar]
  49. Li Z.F. Luo F.Y. synthesis and characterization of n-substituted phenyl-n′-[6-(2-chlorobenzothiazol)yl]urea. Chem. Res. Application 2001 13 1 80 82
    [Google Scholar]
  50. Liu Q. Hou X.M. One-pot three-component synthesis of 3-Methyl-4-Arylmethylene- Isoxazol-5(4H)- ones catalyzed by sodium sulfide. Phosphorus Sulfur Silicon Relat. Elem 2012 187 4 448 453 10.1080/10426507.2011.621003
    [Google Scholar]
/content/journals/cos/10.2174/0115701794344307241027093947
Loading
Synthesis and Characterization of 3-S-impurities in Timolol Maleate
Bentham Science Publishers ; https://doi.org/10.2174/0115701794344307241027093947
/content/journals/cos/10.2174/0115701794344307241027093947
/content/journals/cos/10.2174/0115701794344307241027093947
Loading

Data & Media loading...

Supplements

Supplementary material is available on the publisher's website along with the published article.

file format download Download

  • Article Type:     Research Article
Keywords: β-adrenergic receptor blocker ; quality control ; new impurity ; 3-S-timolol ; clinical safety ; Timolol maleate

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test